Bone Conduction
by Rebecca Steinke

TECH Talk: Michelle Kraskin, Au.D., on the Cochlear™ Baha® SoundArc

April 18, 2019
Share

TECH Talks

Michelle Kraskin, Au.D., explains what she loves about the Cochlear™ Baha® SoundArc, a new non-surgical option for children with single-sided deafness (SSD) or a conductive hearing loss.

In her TECH Talk, Dr. Kraskin discusses how her patients and their parents have been loving the Baha SoundArc as a non-surgical solution with the Baha System. She says it is great for pediatric patients with single-sided deafness (SSD), microtia atresia and unilateral hearing loss. Dr. Kraskin says the SoundArc is a great option for older children who no longer want to wear the Softband, but are not yet appropriate for surgery.

The Baha SoundArc is more discrete than the Softband and has great retention that stays in place, even for an active child. The Baha SoundArc is comfortable and easy to fit to any patient’s head. It provides the same sound quality as the Softband and can be used with any of the Cochlear Baha 5 Sound Processors, unilaterally or bilaterally.

For more TECH Talk videos from industry experts, please stay up-to-date with the ProNews blog and visit our TECH Talks page.

Related Posts
Computer

Finding Cochlear™ Baha® upgrade patients in Noah® 4

March 29, 2021

By Danielle Clark, Product Marketing Manager, Recipient Services

Our newest technology is designed to help your patients hear their best. Although you know there are patients that could benefit from upgrading to new technology, it may initially seem like a complicated process to identify them in order to start these discussions. However, Noah® 4 can serve as a helpful resource to quickly get a list of your upgrade eligible patients. The patient search function in Noah 4 can be used to identify patients who may be eligible for an upgrade.   

Baha patients

1. Click the Advanced search button in Noah 4 and ensure any prior search values are cleared, by using the ‘Clear’ button (see figure 1).

Fig. 1

2. Select a fitting end date that matches typical reimbursement requirements – typically five years is the time period for the “useful life” of a sound processor for many insurance providers. For example, to find patients with a sound processor that is five years old as of January 1, 2021, enter January 1, 2016 (01/01/2016) as the fitting end date to find all patients fitted before this date. (See figure 2).

Fig. 2

3. Leave the fitting start date blank, or enter a fitting start date to narrow down the search.

4. Select Cochlear as a manufacturer.

5. Click ‘Search.’

6. A list of Baha patients eligible for an upgrade will appear in the Noah patient browser.

To find more information about upgrading to share with your patients visit www.Cochlear.com/US/Upgrade.

“Noah” is a registered trademark of HIMSA II K/S in the USA. Outside the USA, “Noah” is a trademark of HIMSA II K/S.

Cochlear receives FDA clearance to lower the age for the Osia® System to 5 years old

April 19, 2024
  • In the United States, the Osia System is now cleared for children ages 5 and older
  • The Osia System, which launched commercially in 2020, is indicated for people with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness (SSD)
  • The Osia System has been shown to provide clinically significant improvements high frequency hearing for children.2,3,4

Lone Tree, Colo. (April 19, 2024) – Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) clearance to lower the age of the Cochlear™  Osia System from 12 years-old to 5 years-old for children with conductive hearing loss, mixed hearing loss and single-sided sensorineural deafness (SSD).

The Osia System is a new category of bone conduction hearing solutions that uses digital piezoelectric stimulation to bypass damaged areas of the natural hearing system to send sound vibrations directly to the inner ear (cochlea). It is the first and only active bone conduction system that allows patients to undergo MRI scans at both 1.5 T and 3.0 T without the need for surgery.1

Now children as young as 5 will be able to have full access to the Osia System’s unique technology that is optimized to deliver high power and clarity, especially in high-frequency sounds, which are important for hearing what others are saying.

“I love my Osia. It’s given me the confidence to succeed in school. I can hear everything my teacher and my friends say,” Adrian R., 8-year-old Osia System recipient said.

Adrian was diagnosed with hearing loss at age 4 and started with the Baha® Sound Processor with a Baha Softband before transitioning to the Osia System at age 6.

“It has been amazing to see the transformation in Adrian. She has been doing so well in school and is able to keep up with her friends both in school and out. She is even learning the piano now and I never thought I would be able to say that. It has truly been life changing,” Dea R., parent to 8-year-old Adrian said.

The Osia System has been shown to provide clinically significant improvements in high frequency hearing for children.2,3,4

“I choose the Osia System for my pediatric patients because it really made the difference in terms of the sound clarity. It is absolutely incredible,” Dr. Daniela Carvalho, Pediatric Otolaryngologist at Rady Children’s Hospital said.

“All of my patients with the Osia System have come back to my office saying it’s the first time they’ve heard the birds chirping or other high-frequency sounds.”

Cochlear’s product portfolio is inspired by meaningful innovation and a core belief that technology is only as useful as the benefit it provides.

“The Osia System is transformative technology, and we’re pleased that it’s now accessible for children as young as 5. This aligns with our commitment to empower people across all stages of life to stay connected and thrive,” Lisa Aubert, President, Cochlear North America said.

About Cochlear Limited (ASX: COH)
People have always been Cochlear’s inspiration, ever since Professor Graeme Clark set out to create the first multi-channel cochlear implant after seeing his father struggle with hearing loss.  Since 1981, Cochlear has provided more than 750,000 devices in more than 180 countries, helping people of all ages around the world to hear.  As the global leader in implantable hearing solutions, Cochlear connects people with life’s opportunities, and welcomes them to the world’s largest hearing implant community.

Cochlear has a global workforce of around 4,800 people, with a passion for progress, who strive to meet the needs of people living with hearing loss. The company continually innovates to anticipate future needs, investing more than AUD$2.7 billion to date in research and development to push the boundaries of technology and help more people hear.

For further information please contact:
Christy LaPlante – PR Manager Cochlear Americas
E: pr-cochlearamericas@cochlear.com

  1. Ellsperman SE, Nairn EM, Stucken EZ. Review of Bone Conduction Hearing Devices. Audiol Res. 2021;11(2):207-219.
  2.  ClinicalTrials.Gov ID NCT 0500931
  3.  You, P., A. Choi, J. Drob, S. M. Hunsaker, Y. C. Liu, and R. Silva. 2022. ‘Early Outcomes of a New Active Transcutaneous Bone Conduction Implant in Pediatric Patients’, Otol Neurotol, 43: 212-18.
  4. Florentine, M. M., J. Virbalas, and D. K. Chan. 2022. ‘Early surgical and audiologic outcomes of active, transcutaneous, osseointegrated bone-conduction hearing device (Osia 2® system) placement’, International Journal of Pediatric Otorhinolaryngology, 156.

In the United States and Canada, the Osia System is indicated for ages 5 and older.

© Cochlear Limited 2024. All rights reserved.



Cochlear logo - white

©Cochlear Limited 2024. All rights reserved. ACE, Advance Off-Stylet, AOS, Ardium, AutoNRT, Autosensitivity, Baha, Baha SoftWear, BCDrive, Beam, Bring Back the Beat, Button, Carina, Cochlear, 科利耳, コクレア, 코클리어, Cochlear SoftWear, Contour, コントゥア, Contour Advance, Custom Sound, DermaLock, Freedom, Hear now. And always, Hugfit, Human Design, Hybrid, Invisible Hearing, Kanso, LowPro, MET, MP3000, myCochlear, mySmartSound, NRT, Nucleus, Osia, Outcome Focused Fitting, Off-Stylet, Piezo Power, Profile, Slimline, SmartSound, Softip, SoundArc, True Wireless, the elliptical logo, Vistafix, Whisper, WindShield and Xidium are either trademarks or registered trademarks of the Cochlear group of companies. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

 

This material is intended for health professionals. If you are a consumer, please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

 

Cochlear ProNews is monitored Monday through Friday, excluding some holidays. Questions and inquiries submitted over the weekends or holidays may see a delay in response. For immediate assistance please contact us directly. You are solely responsible for your interactions with other members of our Websites. Cochlear reserves the right, but has no obligation, to monitor disputes or communications between you and other members of our Websites. For a full list of Cochlear’s terms of use, click here.